Be part of stomach & oesophageal cancer research

15th February 2021

Have you, or someone you care for, been given a medication called Lonsurf for treatment of advanced stomach cancer and cancer of the oesophageal (gullet)/stomach junction? Or have you had at least two whole body treatments for advanced cancer and are now being given best supportive care?

Please consider completing this survey, that will help inform future medications.

Trifluridineā€“tipiracil (Lonsurf) is a cancer medicine (chemotherapy) for the treatment of adult patients with stomach cancer and cancer of the junction between the stomach and gullet. This medication is proposed to be used for people who have been previously treated with at least two whole body treatments for advanced cancer.

This medicine (chemotherapy) is proposed for treatment when most people would only be given best supportive care for their cancer as a third treatment. It is very unusual to receive more than two chemotherapy treatments because of lack of evidence of benefit to patients.

The Scottish Medicines Consortium (SMC) is committed to working in partnership with patient groups to capture patient and carer experiences and use these to inform decision-making with regards to approval of medicines for use in Scotland. They are requesting the opinion of patients and carers of patients with these cancers about the use of this treatment. If you are living in the UK and have tried this treatment; or are living with best supportive care for cancer; or are a carer for someone with these advanced cancers, we would like to hear your views on living with this diagnosis and what the possible benefits and drawbacks are of this treatment.

The deadline for completing this survey is 22nd February 2021.

Click here to complete the survey. You will play your part in informing future medications.

DISCOVER MORE:

Read more posts...

The World’s 1st Microscopic Colitis Awareness Week!

Guts UK is proud to organise the World’s 1st Microscopic Colitis Awareness Week. Raising awareness of microscopic colitis is so important, as there are simply too many people living undiagnosed in the UK. This week...

12th April 2021

Bowel Cancer Awareness Month 2021

As well as IBS Awareness Month, April marks Bowel Cancer Awareness Month too. Every day in the UK, 113 people are diagnosed with bowel cancer and 44 people die. What is bowel cancer? It is...

7th April 2021

IBS Awareness Month 2021

Did you know that Irritable Bowel Syndrome (IBS) affects approximately 1 in 20 of us in the UK? That is 3.2 million people! If you’re not affected by IBS yourself, it’s likely you have friends...

31st March 2021

Chronic Pancreatitis and COVID-19

The COVID-19 pandemic has changed life for everyone with major changes to the way we currently live our lives. The promise of hope is on the horizon with better understanding of the virus and the...

26th February 2021

How we use YOUR donations to change & save lives

Guts UK has three charitable objectives: Provide expert information to patients Raise awareness of digestive health Fund research into the digestive system from top to tail; the gut, liver and pancreas At Guts UK, we...

28th October 2020